You have 9 free searches left this month | for more free features.

Nasal insulin

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Insulin Trial in Baton Rouge (Insulin, Regular, Human, Placebo)

Active, not recruiting
  • Insulin
  • Insulin, Regular, Human
  • Placebo
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Aug 16, 2022

Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

Not yet recruiting
  • Central Insulin Resistance
  • +2 more
  • Human nasal insulin
  • Placebo
  • (no location specified)
May 12, 2023

Insulin Resistance Trial in Tübingen (nasal insulin, spray)

Recruiting
  • Insulin Resistance
  • nasal insulin
  • placebo spray
  • Tübingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Mar 25, 2022

Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (drug, other, device)

Active, not recruiting
  • Mild Cognitive Impairment
  • Cognitive Impairment
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jan 27, 2023

Mild Cognitive Impairment, Cognitive Impairment, Alzheimer, Early Onset Trial (Insulin (Humulin® R U-100), Placebo, Aptar Pharma

Not yet recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Insulin (Humulin® R U-100)
  • +2 more
  • (no location specified)
May 31, 2022

MDD Trial in Toronto (Humalog, Saline nasal spray)

Recruiting
  • Major Depressive Disorder
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 5, 2022

Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Trial in Winston-Salem (Insulin (Humulin® R U-100), Empagliflozin 10

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Insulin (Humulin® R U-100)
  • +4 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences / Wake Forest School of M
Nov 10, 2021

Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem, Tacoma (Saline, Insulin detemir, Insulin)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Winston-Salem, North Carolina
  • +1 more
Nov 13, 2020

Ischemic Heart Disease, Aortic Aneurysm Trial in Montreal (Humulin R, Normal Saline)

Recruiting
  • Ischemic Heart Disease
  • Aortic Aneurysm
  • Humulin R
  • Normal Saline
  • Montreal, Quebec, Canada
    Royal Victoria Hospital McGill University Health Centre
Feb 23, 2021

Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly &

Active, not recruiting
  • Mild Cognitive Impairment
  • Cognitive Impairment
  • 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
  • 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Nov 2, 2021

Insulin Resistance, Obesity Trial in Tübingen (Human nasal insulin, Placebo)

Completed
  • Insulin Resistance
  • Obesity
  • Human nasal insulin
  • Placebo
  • Tübingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Nov 4, 2020

Alzheimer's Disease, Mild Cognitive Impairment Trial in Winston-Salem (Insulin aspart, Placebo)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Insulin aspart
  • Placebo
  • Winston-Salem, North Carolina
    Wake Forest Baptist Hospital
May 8, 2020

Out-Of-Hospital Cardiac Arrest, Healthy Trial in Ann Arbor (Intranasal insulin)

Completed
  • Out-Of-Hospital Cardiac Arrest
  • Healthy
  • Intranasal insulin
  • Ann Arbor, Michigan
    University of Michigan
Oct 13, 2022

Healthy Trial in Ann Arbor (Intranasal insulin)

Recruiting
  • Healthy
  • Intranasal insulin
  • Ann Arbor, Michigan
    University of Michigan
Nov 16, 2023

Amnestic Mild Cognitive Impairment, Alzheimer's Disease Trial in United States (Insulin (Humulin® R U-100), Placebo)

Completed
  • Amnestic Mild Cognitive Impairment
  • Alzheimer's Disease
  • Insulin (Humulin® R U-100)
  • Placebo
  • Phoenix, Arizona
  • +24 more
May 14, 2020

Asthma, Obesity, Insulin Resistance Trial in Birmingham (Probiotic, Placebo)

Not yet recruiting
  • Asthma
  • +2 more
  • Probiotic
  • Placebo
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 7, 2023

Diabetes, Type 2 Trial in Tuebingen (intranasal insulin, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • intranasal insulin
  • Placebo
  • Tuebingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Jun 24, 2021

Insulin Sensitivity Trial in Tuebingen (intranasal insulin, Placebo spray)

Completed
  • Insulin Sensitivity
  • intranasal insulin
  • Placebo spray
  • Tuebingen, Germany
    University of Tuebingen, Department of Internal Medicine IV
Sep 2, 2021

Healthy, Vasodilation, Insulin Resistance Trial in Columbia (Carbon dioxide breathing, Neurovascular Coupling, Human insulin)

Recruiting
  • Healthy
  • +3 more
  • Carbon dioxide breathing
  • +2 more
  • Columbia, Missouri
    University of Missouri
Feb 3, 2022

Postoperative Neurocognitive Disorders Trial in Xi'an (Intranasal insulin, Intranasal saline)

Recruiting
  • Postoperative Neurocognitive Disorders
  • Intranasal insulin
  • Intranasal saline
  • Xi'an, Shannxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 6, 2022

Type 2 Diabetic Patients: Real-life Study on Effectiveness and

Not yet recruiting
  • Diabete Type 2
    • (no location specified)
    Nov 2, 2023

    Insulin Resistance, Inflammatory Markers Trial in Cairo (low level laser in addition to diet recommendations, sham laser

    Recruiting
    • Insulin Resistance
    • Inflammatory Markers
    • low level laser in addition to diet recommendations
    • sham laser application in addition to diet recommendations
    • Cairo, Egypt
      Physical Therapy
    Jun 17, 2022

    Hypoglycemia Unawareness, Type 1 Diabetes Trial in Minneapolis (intra-nasal naloxone, Intra-nasal saline)

    Terminated
    • Hypoglycemia Unawareness
    • Type 1 Diabetes
    • intra-nasal naloxone
    • Intra-nasal saline
    • Minneapolis, Minnesota
      Clinical and Translational Science Institute, University of Minn
    Sep 26, 2022

    Hypoglycemia Trial in Montreal (Nasal Glucagon 1 mg, Nasal Glucagon 2 mg, SC Glucagon)

    Completed
    • Hypoglycemia
    • Nasal Glucagon 1 mg
    • +3 more
    • Montreal, Quebec, Canada
      Algorithme Pharma
    Sep 5, 2019